Related references
Note: Only part of the references are listed.Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases
Antonio Pea et al.
ANNALS OF SURGERY (2020)
Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
Wenzel M. Hackeng et al.
ENDOCRINE PATHOLOGY (2020)
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation
Monica Sofia Ventura Ferreira et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis
Rita T. Lawlor et al.
BMC CANCER (2019)
Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood
Simone Minasi et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
In perspective: An update on telomere targeting in cancer
Eric T. Sugarman et al.
MOLECULAR CARCINOGENESIS (2019)
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
Andrea Mafficini et al.
ENDOCRINE REVIEWS (2019)
Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar et al.
GENES (2018)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
Joo Young Kim et al.
CLINICAL CANCER RESEARCH (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
Christopher J. VandenBussche et al.
CANCER CYTOPATHOLOGY (2017)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
Alternative Lengthening of Telomeres Predicts Site of Origin in Neuroendocrine Tumor Liver Metastases
Epameinondas Dogeas et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2014)
Assembly of telomeric chromatin to create ALTernative endings
Roderick J. O'Sullivan et al.
TRENDS IN CELL BIOLOGY (2014)
WHO Classification of Soft Tissue and Bone, fourth edition: summary and commentary
Andrew E. Rosenberg
CURRENT OPINION IN ONCOLOGY (2013)
Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
Christopher M. Heaphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Alternative lengthening of telomeres in mammalian cells
JD Henson et al.
ONCOGENE (2002)
Telomerase in cancer and aging
MP Granger et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Telomerase and cancer
JW Shay et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
